Metropolitan Life Insurance CO Cardiovascular Systems Inc Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

36 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$13.31 - $19.86 $6,841 - $10,208	-514 Reduced 18.86%	2,212 $43,000
Q4 2022 Jun 14, 2023	BUY	$12.74 - $15.12 $6,548 - $7,771	514 Added 23.24%	2,726 $37.1 Million
Q3 2022 Jun 14, 2023	BUY	$12.93 - $17.17 $6,646 - $8,825	514 Added 23.24%	2,726 $37.8 Million
Q2 2022 Jun 20, 2023	BUY	$13.53 - $23.34 $6,954 - $11,996	514 Added 23.24%	2,726 $39,000
Q1 2022 Jun 20, 2023	BUY	$16.14 - $22.6 $8,295 - $11,616	514 Added 23.24%	2,726 $61,000
Q1 2022 Mar 30, 2023	SELL	$16.14 - $22.6 $145,050 - $203,106	-8,987 Reduced 76.73%	2,726 $61,000
Q1 2022 May 12, 2022	SELL	$16.14 - $22.6 $145,050 - $203,106	-8,987 Reduced 76.73%	2,726 $62,000
Q4 2021 Jun 21, 2023	BUY	$18.64 - $36.77 $177,098 - $349,351	9,501 Added 429.52%	11,713 $219,000
Q3 2021 Jun 21, 2023	BUY	$32.83 - $43.0 $311,917 - $408,543	9,501 Added 429.52%	11,713 $384,000
Q2 2021 Jun 21, 2023	BUY	$34.41 - $44.03 $326,929 - $418,329	9,501 Added 429.52%	11,713 $499,000
Q2 2021 Mar 30, 2023	BUY	$34.41 - $44.03 $26,805 - $34,299	779 Added 7.12%	11,713 $499,000
Q2 2021 Aug 16, 2021	BUY	$34.41 - $44.03 $402,665 - $515,239	11,702 Added 106381.82%	11,713 $500,000
Q1 2021 Jun 26, 2023	BUY	$37.29 - $47.19 $325,243 - $411,591	8,722 Added 394.3%	10,934 $419 Million
Q1 2021 Mar 30, 2023	SELL	$37.29 - $47.19 $14,170 - $17,932	-380 Reduced 3.36%	10,934 $419,000
Q1 2021 May 14, 2021	SELL	$37.29 - $47.19 $421,488 - $533,388	-11,303 Reduced 99.9%	11 $419,000
Q4 2020 Jun 22, 2023	BUY	$34.3 - $44.09 $312,198 - $401,307	9,102 Added 411.48%	11,314 $495,000
Q3 2020 Jun 26, 2023	BUY	$27.86 - $39.35 $253,581 - $358,163	9,102 Added 411.48%	11,314 $445,000
Q3 2020 Mar 30, 2023	BUY	$27.86 - $39.35 $27,832 - $39,310	999 Added 9.68%	11,314 $445,000
Q3 2020 Nov 13, 2020	BUY	$27.86 - $39.35 $27,832 - $39,310	999 Added 9.68%	11,314 $445,000
Q2 2020 Jun 26, 2023	BUY	$30.3 - $42.55 $245,520 - $344,782	8,103 Added 366.32%	10,315 $325,000
Q1 2020 Jul 12, 2023	BUY	$30.0 - $54.18 $243,090 - $439,020	8,103 Added 366.32%	10,315 $363,000
Q1 2020 Mar 30, 2023	SELL	$30.0 - $54.18 $33,210 - $59,977	-1,107 Reduced 9.69%	10,315 $363,000
Q1 2020 May 15, 2020	SELL	$30.0 - $54.18 $33,210 - $59,977	-1,107 Reduced 9.69%	10,315 $363,000
Q4 2019 Jul 12, 2023	BUY	$42.29 - $52.2 $389,490 - $480,762	9,210 Added 416.37%	11,422 $554,000
Q3 2019 Jul 12, 2023	BUY	$42.06 - $51.64 $387,372 - $475,604	9,210 Added 416.37%	11,422 $542,000
Q2 2019 Jul 12, 2023	BUY	$33.93 - $43.66 $312,495 - $402,108	9,210 Added 416.37%	11,422 $490,000
Q1 2019 Jul 13, 2023	BUY	$26.74 - $41.32 $246,275 - $380,557	9,210 Added 416.37%	11,422 $441,000
Q1 2019 Mar 30, 2023	BUY	$26.74 - $41.32 $232,531 - $359,318	8,696 Added 319.0%	11,422 $441,000
Q1 2019 May 16, 2019	SELL	$26.74 - $41.32 $389,441 - $601,784	-14,564 Reduced 56.05%	11,422 $441,000
Q1 2019 May 15, 2019	BUY	$26.74 - $41.32 $389,441 - $601,784	14,564 Added 127.51%	25,986 $250,000
Q4 2018 Jul 13, 2023	BUY	$25.26 - $38.43 $232,644 - $353,940	9,210 Added 416.37%	11,422 $325,000
Q4 2018 Feb 14, 2019	BUY	$25.26 - $38.43 $227,036 - $345,408	8,988 Added 369.27%	11,422 $325,000
Q3 2018 Jul 13, 2023	BUY	$33.27 - $39.25 $306,416 - $361,492	9,210 Added 416.37%	11,422 $447 Million
Q3 2018 Nov 14, 2018	SELL	$33.27 - $39.25 $299,030 - $352,779	-8,988 Reduced 78.69%	2,434 $95,000
Q4 2017 Feb 15, 2018	SELL	$23.37 - $29.26 $251,367 - $314,720	-10,756 Reduced 48.5%	11,422 $271,000
Q2 2017 Aug 14, 2017	BUY	N/A	22,178	22,178 $715,000

Others Institutions Holding CSII

# of Institutions

Shares Held

35.5K

Call Options Held

Put Options Held

View Full List

About Cardiovascular Systems Inc

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

More about CSII

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account